1CM
RGEN icon

1492 Capital Management’s Repligen RGEN Stock Holding History

1492 Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,623
Closed -$1.06M – 126
2022
Q1 		$1.06M Buy
+5,623
New +$1.07M 0.56% 61
2020
Q2 		– Sell
-2,752
Closed -$266K – 93
2020
Q1 		$266K Buy
+2,752
New +$266K 0.32% 68

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

1492 Capital Management's RGEN Position: Q2 2022 in Review

1492 Capital Management sold out of Repligen (RGEN) in Q2 2022, closing a stake of 5,623 shares — an estimated $1.06M sold.

1492 Capital Management first reported a position in RGEN in Q1 2020 and held it in 2 quarters. The position peaked at $1.06M in Q1 2022. 405 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • 1492 Capital Management reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • 1492 Capital Management sold 5,623 Repligen shares in Q2 2022, an estimated $1.06M.
  • 1492 Capital Management first reported a position in Repligen in Q1 2020 and held it in 2 quarters.
  • 1492 Capital Management's Repligen position peaked at $1.06M in Q1 2022.
  • 405 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on 1492 Capital Management's 13F filing for Q2 2022, filed 10 Aug 2022.